Back to results
US 7,968,565 B2Granted
Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
AssigneeSunesis Pharmaceuticals, Inc.
InventorsMichelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
Life of this patent
Estimating the term…
Abstract
The present invention relates to SNS-595 and methods of treating cancer using the same.
Claims1
A combination comprising:
- a) a therapeutically effective amount of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and b) a therapeutically effective amount of cytarabine.
Dependencies are inferred from the claim text.